Citations

Mayo Clinic

Showing 10 of 108304 citations.

Titin Isoforms, Extracellular Matrix, and Global Chamber Remodeling in Experimental Dilated Cardiomyopathy
Jaber, Wissam , Maniu, Calin V., Krysiak, Judith , Shapiro, Brian P. , Meyer, Donna , Linke, Wolfgang A. , Redfield, Margaret M. , Linke, Wolfgang A

Circulation: Heart Failure | June 26, 2008 | Volume: 1 | Issue: 3 | Pages: 192-199

10.1161/circheartfailure.108.768465 | PMID 19808289 Get It

Background— Altered titin isoforms may modify cardiac function in heart failure (HF), but the nature of isoform switches and associated functional implications are not well defined. Limited studies have reported an increased compliant isoform (N2BA) expression in human systolic HF. Titin may also modulate stretch-regulated responses such as myocardial natriuretic peptide production. Methods and Results— We characterized titin isoform expression and extracellular matrix in all 4 cardiac chambers and the left ventricular (LV) epicardium and endocardium in normal dogs (n=6) and those with HF (n=6) due to tachypacing and characterized functional implications at the LV myofiber and chamber level. Recognizing the potential for uncoupling of the extracellular matrix and cardiomyocyte in tachypacing, myocardial natriuretic peptide production, a molecular marker of stretch-regulated responses, was also assessed. All chambers were dilated in HF, but the extracellular matrix was not increased. HF dogs had markedly lower N2BA in the atria and right ventricle. In failing LVs, N2BA was decreased only in the epicardium, where myofiber passive stiffness was increased. However, LV chamber mechanics were driven by the marked LV dilatation, with no increase in LV diastolic stiffness. Natriuretic peptide concentrations increased markedly in the endocardium in relation to increases in LV wall stress. Conclusions— Tachypacing HF is characterized by decreases in compliant titin isoform expression in the atria, right ventricle, and LV epicardium. However, LV chamber mechanics are principally determined by geometric and extracellular matrix changes rather than titin-based myofiber stiffness in this model. Stretch-regulated myocardial responses (natriuretic peptide production) appeared intact, suggesting that the mechanotransduction role of titin was not impaired in HF.
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
Rassenti, Laura Z., Jain, Sonia , Keating, Michael J. , Wierda, William G. , Grever, Michael R. , Byrd, John C. , Brown, Jennifer R. , Greaves, Andrew, Rai, Kanti R., Byrd, John C. , Kay, Neil E. , Gribben, John G. , Neuberg, Donna , He, Feng , Rai, Kanti R., Kipps, Thomas J. , Byrd, John C

Blood | June 25, 2008 | Volume: 112 | Issue: 5 | Pages: 1923-1930

10.1182/blood-2007-05-092882 | PMID 18577710 Get It

AbstractLeukemia-cell expression of ZAP-70, CD38, or unmutated immunoglobulin heavy chain variable region genes (U-IGHV) each is associated with aggressive disease in patients with chronic lymphocytic leukemia (CLL). To assess the relative strength of each marker, we defined thresholds for designating a case as positive for CD38 or ZAP-70 in a test cohort of 307 patients and used these data-defined criteria to stratify patients in an independent cohort of 705 patients. Multivariable analysis revealed that ZAP-70 was the strongest risk factor. Knowledge of the IGHV mutation status or CD38 did not improve our ability to predict the time to first treatment except for ZAP-70–negative cases, which could be segregated into 2 groups of intermediate-risk or low-risk disease based on whether they expressed unmutated or mutated IGHV. ZAP-70 maintained its high relative prognostic value for the subset of patients with early-stage, asymptomatic disease, including patients evaluated within 1 year of diagnosis. Although it is premature to recommend therapy based on these risk factors, patients with ZAP-70–positive CLL cells should be monitored closely for disease progression as they have a median time from diagnosis to requiring initial therapy by standard criteria of approximately 3 years.
Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
Myers, Rae, Harvey, Mary, Greiner, Suzanne , Krempski, James , Raffel, Corey , Shelton, Steven E., Soeffker, Diane, Zollman, Paula J., Federspiel, Mark J. , Blanco, Michael, Kaufmann, Timothy J. , Galanis, Evanthia , Krempski, James W

Human Gene Therapy | June 24, 2008 | Volume: 19 | Issue: 7 | Pages: 690-698

10.1089/hum.2008.035 | PMID 18576918 Get It

Extracardiac Venous Heterotaxy Syndrome
Alharthi, Mohsen, Mookadam, Farouk , Collins, Joseph M. , Chandrasekaran, Krishnaswamy , Scott, Luis R. , Tajik, A. Jamil

Circulation | June 23, 2008 | Volume: 117 | Issue: 25 | Pages: No page available

10.1161/circulationaha.107.741041 | PMID 18574050 Get It

A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use
Formea, Christine M. , Weiss, William T., McCluskey, Susan V

American Journal of Health-System Pharmacy | June 23, 2008 | Volume: 65 | Issue: 13 | Pages: 1266-1269

10.2146/ajhp070497 | PMID 18574018 Get It

Gang of 3 in aggressive CLL?
Nowakowski, Grzegorz S.

Blood | June 23, 2008 | Volume: 112 | Issue: 1 | Pages: 5-6

10.1182/blood-2008-03-147140 | PMID 18574035 Get It

Biologic and genetic characterization of the novel amyloidogenic lambda light chain–secreting human cell lines, ALMC-1 and ALMC-2
Arendt, Bonnie K., Ramı́rez-Alvarado, Marina , Sikkink, Laura A., Keats, Jonathan J. , Ahmann, Gregory , Dispenzieri, Angela , Fonseca, Rafaël , Ketterling, Rhett P. , Knudson, Ryan A., Mulvihill, Erin M., Tschumper, Renee C. , Wu, Xiaosheng , Zeldenrust, Steven R., Jelinek, Diane F., Dispenzieri, Angela , Ramirez-Alvarado, Marina , Ketterling, Rhett P , Keats, Jonathan J , Fonseca, Rafael

Blood | June 21, 2008 | Volume: 112 | Issue: 5 | Pages: 1931-1941

10.1182/blood-2008-03-143040 | PMID 18567838 Get It

AbstractPrimary systemic amyloidosis (AL) is a rare monoclonal plasma cell (PC) disorder characterized by the deposition of misfolded immunoglobulin (Ig) light chains (LC) in vital organs throughout the body. To our knowledge, no cell lines have ever been established from AL patients. Here we describe the establishment of the ALMC-1 and ALMC-2 cell lines from an AL patient. Both cell lines exhibit a PC phenotype and display cytokine-dependent growth. Using a comprehensive genetic approach, we established the genetic relationship between the cell lines and the primary patient cells, and we were also able to identify new genetic changes accompanying tumor progression that may explain the natural history of this patient's disease. Importantly, we demonstrate that free lambda LC secreted by both cell lines contained a beta structure and formed amyloid fibrils. Despite absolute Ig LC variable gene sequence identity, the proteins show differences in amyloid formation kinetics that are abolished by the presence of Na2SO4. The formation of amyloid fibrils from these naturally secreting human LC cell lines is unprecedented. Moreover, these cell lines will provide an invaluable tool to better understand AL, from the combined perspectives of amyloidogenic protein structure and amyloid formation, genetics, and cell biology.
Don't Mention It
Steensma, David P. , Steensma, David P

Journal of Clinical Oncology | June 18, 2008 | Volume: 26 | Issue: 18 | Pages: 3083-3084

10.1200/jco.2008.17.7238 | PMID 18565895 Get It

In Reply
Leibovich, Bradley C. , Sheinin, Yuri, Lohse, Christine M. , Thompson, R. Houston, Cheville, John C. , Závada, J, Kwon, Eugene D.

Journal of Clinical Oncology | June 18, 2008 | Volume: 26 | Issue: 18 | Pages: 3107-3109

10.1200/jco.2008.16.2164 Get It

Progenitor Cell Therapy in a Porcine Acute Myocardial Infarction Model Induces Cardiac Hypertrophy, Mediated by Paracrine Secretion of Cardiotrophic Factors Including TGFβ1
Doyle, Brendan, Sorajja, Paul , Hynes, Brian, Kumar, Arun , Araoz, Phillip A., Stalboerger, Paul G., Miller, Dylan V. , Reed, Cynthia , Schmeckpeper, Jeffrey , Wang, Shaohua , Liu, Chunsheng , Krüger, David , Riederer, Stephen J. , Caplice, Noel M. , Sorajja, Paul , Terzic, André

Stem Cells and Development | June 18, 2008 | Volume: 17 | Issue: 5 | Pages: 941-952

10.1089/scd.2007.0214 | PMID 18564032 Get It